Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252941 · ClinicalTrials.gov registry record · Phase 1
Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma
A Phase 1 study of Prostate Cancer and Post-Brachytherapy Bladder Outlet Obstruction, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00252941: Completed Phase 1 study of Prostate Cancer and Post-Brachytherapy Bladder Outlet Obstruction, sponsored by The Cleveland Clinic.
NCT00252941 is a Phase 1 study of Prostate Cancer and Post-Brachytherapy Bladder Outlet Obstruction that has completed, run by The Cleveland Clinic. The registered enrollment target is 20 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252941, a Phase 1 study of Prostate Cancer and Post-Brachytherapy Bladder Outlet Obstruction, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility, safety, and efficacy of the Memokath® 028SW stent to prevent urinary obstructive symptoms (difficulty urinating) when used after prostate seed implantation for the treatment of localized prostate cancer.
Conditions Studied
Interventions
- DEVICE Memokath 028SW Urethral Stent
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
What the finished NCT00252941 record still lists
NCT00252941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Memokath 028SW Urethral Stent is the first listed.
NCT00252941 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00252941 about?
NCT00252941 is a clinical study titled "Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma". The purpose of this study is to determine the feasibility, safety, and efficacy of the Memokath® 028SW stent to prevent urinary obstructive symptoms (difficulty urinating) when used after prostate seed implantation for the treatment of localized prostate cancer.
What is the current status of trial NCT00252941?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-11. Estimated completion is 2006-11.
What conditions does trial NCT00252941 study?
This clinical trial studies the following conditions: Prostate Cancer, Post-Brachytherapy Bladder Outlet Obstruction.
What interventions are being tested in trial NCT00252941?
The interventions under investigation include: Memokath 028SW Urethral Stent (DEVICE).
Who is sponsoring clinical trial NCT00252941?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252941 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00252941's enrollment target sits among peer trials
20 653rd of 735 higher than 69 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RECRUITING · Phase 1
-
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
RECRUITING · Phase 1
-
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia